The Gross Margin of EyePoint Pharmaceuticals Inc (EYPT) is 91.42%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 91.42% |
| 2023-12-31 | 89.93% |
| 2022-12-31 | 79.90% |
| 2021-12-31 | 77.86% |
| 2020-12-31 | 83.07% |
| 2019-12-31 | 86.79% |